Status:
COMPLETED
Iron Overload in Stem Cell Transplant Recipients
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Dana-Farber Cancer Institute
Lance Armstrong Foundation
Conditions:
Iron Overload
Eligibility:
All Genders
5+ years
Brief Summary
The goal of this study is to examine the impact of iron overload in patients undergoing a bone marrow transplant. We believe that the iron status in these patients is associated with complications for...
Eligibility Criteria
Inclusion
- Undergoing allogeneic HSCT for malignant or non-malignant conditions
- Age greater than or equal to 5 years
- Able to undergo MRI without a need for general anesthesia
- No metal implants
- Signed informed consent (by parent if patient is less than 18 years old, or by patient, if he or she is greater than 18 years old).
Exclusion
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00806715
Start Date
February 1 2007
End Date
October 1 2010
Last Update
March 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Boston
Boston, Massachusetts, United States, 02115